Acepodia to Present Preclinical Data on its Gamma Delta T cell Therapy Candidate, ACE1831, at 2022 SITC Annual Meeting ...Middle East

ALAMEDA, Calif., and TAIPEI, Nov. 3, 2022 /PRNewswire/ -- Acepodia, a clinical-stage biotechnology company developing first-in-class cell therapies with its unique antibody-cell conjugation (ACC) technology to address gaps in cancer care, today announced the upcoming poster presentation...

Read More Details
Finally We wish PressBee provided you with enough information of ( Acepodia to Present Preclinical Data on its Gamma Delta T cell Therapy Candidate, ACE1831, at 2022 SITC Annual Meeting )

Also on site :

• BOJ to taper bond buying at a slower pace amid new risks
• G7 leaders urge de-escalation in Middle East, blame Iran for 'instability and terror'
• Tankers Reportedly Ablaze Near Strait of Hormuz